ChemicalBook
English   Japanese   Germany   Korea

7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide

, 66410-51-3, 结构式
CAS号:
66410-51-3
英文名:
7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide
英文别名:
7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide;7-[(Dimethylamino)sulfonyl]-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide;7-(N,N-Dimethylsulfamoyl)-N-((1-methylpyrrolidin-2-yl)methyl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide;1,4-Benzodioxin-5-carboxamide, 7-[(dimethylamino)sulfonyl]-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-
中文名:
中文别名:
CBNumber:
CB6891174
分子式:
C17H25N3O5S
分子量:
383.46
MOL File:
66410-51-3.mol

7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide化学性质

安全信息

7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide性质、用途与生产工艺

7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide 上下游产品信息

上游原料

下游产品


7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide 生产厂家

供应商联系电话电子邮件国家产品数优势度
合肥孚亚生物技术有限公司 18096409024 sales02@foreversyn.com 中国 1953 58
天津普西唐生物医药科技有限公司 010-60605840 psaitong@jm-bio.com 中国 29778 58
 

66410-51-3, 7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide 相关搜索:

  • 66410-51-3
  • 7-(N,N-Dimethylsulfamoyl)-N-((1-methylpyrrolidin-2-yl)methyl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide
  • 1,4-Benzodioxin-5-carboxamide, 7-[(dimethylamino)sulfonyl]-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-
  • 7-[(Dimethylamino)sulfonyl]-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide
  • 7-(N,N-dimethylsulphamoyl)-2,3-dihydro-N-[(1-methyl-2-pyrrolidinyl)methyl]-1,4-benzodioxin-5-carboxamide
Copyright 2016 © ChemicalBook. All rights reserved